Rights and permissions
About this article
Cite this article
How did Abbott avoid generic fenofibrate competition?. Pharmacoecon. Outcomes News 652, 3 (2012). https://doi.org/10.2165/00151234-201206520-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206520-00006